Mar 14, 2026Lifestyle Pilot Shows a Big Alzheimer’s Signal—With CaveatsA 2024 lifestyle trial improved cognition in early Alzheimer's, but its small, open-label design leaves a major question: can it replicate?alzheimer's diseaselecanemabdonanemabRead article →